Performance snapshot
Datwyler recorded sales of CHF538 million in the second half of 2025, marginally below street expectations, yet posted an EBIT margin of 12.6%, exceeding forecasts on the profitability front.
Segment dynamics
The company highlighted a bifurcated performance across its end markets. Healthcare stood out, achieving 10.6% organic growth in 2H25, while Industrial lagged with only 1.5% organic growth over the same period. These divergent trajectories helped shape the group result for the year.
Full-year results and shareholder return
For the full year 2025 Datwyler reported group sales of CHF1.101 billion and an adjusted EBIT margin of 12.4%, an improvement from 12.0% in 2024. Management has tabled a dividend proposal of CHF3.20 per share.
Outlook for 2026
Looking ahead, Datwyler provided a qualitative outlook rather than numerical guidance. The company expects both sales and profitability to increase in 2026. Management anticipates "structural growth" in Healthcare, describes Automotive as facing "broadly flat vehicle production," and characterises Industries as likely to see "stable demand with selective growth."
Governance developments
Datwyler announced planned changes to its supervisory board. Mr. Breu, currently CEO of SFS, is proposed as the new chairman as part of age-related leadership transitions.
Market reaction and analyst view
UBS analysts expect investors to respond positively to the results, citing the robust growth in Healthcare and sequential margin improvements in that segment as key drivers of sentiment.
Key points
- 2H25 sales were CHF538 million with an EBIT margin of 12.6% - profitability beat expectations despite a small sales shortfall.
- Healthcare delivered strong organic growth of 10.6% in 2H25, while Industrial grew 1.5% organically in the same period - these sector outcomes materially influenced full-year results.
- Full-year 2025 sales were CHF1.101 billion with an adjusted EBIT margin of 12.4% versus 12.0% in 2024; a dividend of CHF3.20 per share is proposed.
Risks and uncertainties
- Sales in 2H25 were slightly below expectations, indicating potential sensitivity in revenue delivery - this affects equity investors and market-facing stakeholders.
- The outlook for 2026 is qualitative rather than quantitative, leaving scope for variability in investor interpretation and market reaction.
- Automotive exposure faces the prospect of "broadly flat vehicle production," which could limit upside in the Automotive segment if conditions remain subdued.
Datwyler's results combine improved margin performance with mixed top-line signals across its core segments. Management's qualitative guidance and the planned supervisory board changes will be watched closely by investors as the group moves into 2026.